L
1.06
-0.02 (-1.40%)
| Previous Close | 1.07 |
| Open | 1.02 |
| Volume | 14,260 |
| Avg. Volume (3M) | 197,058 |
| Market Cap | 7,912,499 |
| Price / Sales | 0.420 |
| Price / Book | 4.81 |
| 52 Weeks Range |
| Profit Margin | -19.30% |
| Operating Margin (TTM) | -55.56% |
| Diluted EPS (TTM) | -0.440 |
| Quarterly Revenue Growth (YOY) | -26.90% |
| Quarterly Earnings Growth (YOY) | -99.60% |
| Total Debt/Equity (MRQ) | 331.48% |
| Current Ratio (MRQ) | 0.810 |
| Operating Cash Flow (TTM) | -2.24 M |
| Levered Free Cash Flow (TTM) | -3.77 M |
| Return on Assets (TTM) | -27.21% |
| Return on Equity (TTM) | -287.72% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Integrated Freight & Logistics (US) | Bearish | Bearish |
| Integrated Freight & Logistics (Global) | Bearish | Bearish | |
| Stock | Lakeside Holding Limited | - | - |
AIStockmoo Score
-0.5
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services. |
|
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Investment Style | Small Core |
| % Held by Insiders | 76.01% |
| % Held by Institutions | 0.39% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Mar 2025 | Announcement | LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION |
| 14 Feb 2025 | Announcement | Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results |
| 21 Jan 2025 | Announcement | Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |